By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Regen BioPharma  

4700 Spring Street
Suite 304
La Mesa  California  91942  U.S.A.
Phone: 619-702-1404 Fax: 619-330-2328


Company News
Regen BioPharma Expands Research Capacity With New Laboratory Facilities 3/24/2015 11:11:40 AM
Regen BioPharma Receives Green Light From FDA To Proceed With GLP Safety Study In Support Of Its Hemaxellerate Investigational New Drug Application 3/18/2015 1:09:53 PM
Regen BioPharma Acquires Issued Patent And Preclinical Data Package For Targeting Cancer Stem Cell 3/10/2015 11:47:14 AM
Regen BioPharma Files Patent Application For Treatment Of Myelodysplastic Syndrome Utilizing Gene Silencing Therapy 3/3/2015 10:05:04 AM
Regen BioPharma Announces Preferred Stock Dividend 2/25/2015 1:56:59 PM
Regen BioPharma Comments On Dcellvax Cancer IDO-Targeting Technology In Relation To Bristol-Myers Squibb (BMY)-Flexus Biosciences Announcement 2/25/2015 1:54:57 PM
Regen BioPharma Expands Management Team With The Addition Of New CFO Todd Caven 2/17/2015 10:02:54 AM
Regen BioPharma Provides Update On Company's Progress And Areas Of Specialization For 2015 1/15/2015 9:43:11 AM
Regen BioPharma Identifies Second Generation Gene Silencing Candidates For Blocking Cancer Stem Cell Gene Target 1/9/2015 9:09:31 AM
Regen BioPharma Presented Novel Therapeutic Target For Leukemia And Myelodysplastic Syndrome At The American Society of Hematology Annual Meeting 12/12/2014 11:27:06 AM